Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:27-32
Published online before print November 6, 2008, doi: 10.1161/ATVBAHA.108.169623
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/1/27    most recent
ATVBAHA.108.169623v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tarín, C.
Right arrow Articles by Zaragoza, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tarín, C.
Right arrow Articles by Zaragoza, C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:27.)
© 2009 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Endothelial Nitric Oxide Deficiency Reduces MMP-13–Mediated Cleavage of ICAM-1 in Vascular Endothelium

A Role in Atherosclerosis

Carlos Tarín; Monica Gomez; Enrique Calvo; Juan Antonio López; Carlos Zaragoza

From the Fundación Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029 Madrid, Spain.

Correspondence to Carlos Zaragoza, Fundación CNIC, Melchor Fernández Almagro 3, 28029 Madrid, Spain. E-mail czaragoza{at}cnic.es

Objective— Lack of endothelial nitric oxide synthase worsens atherosclerosis at least by increasing monocyte adhesion to endothelial cells. The purpose of this study was to elucidate the molecular mechanism elicited by NO.

Methods and Results— We evaluated atherosclerosis in apoE and NOS3/apoE-deficient mice fed with high-cholesterol diet. We found significant increase in aortic lesion size, and infiltration of macrophages in NOS3/apoE-null mice when compared to apoE-deficient animals. To test the relevance of cellular adhesion as well as extracellular matrix degradation, we evaluated ICAM-1, VCAM-1, PECAM-1, MMP-2, MMP-9, MMP-12, MT1-MMP, and MMP-13 levels in mouse aortas. Lack of NO inhibits MMP-13 and increases ICAM-1 levels in atherosclerosis as compared to apoE-null mice. Ectopically expression of ICAM-1 in eukaryotic cells revealed that extracellular domain of ICAM-1 harbors a substrate recognized by MMP-13. Incubation of COS-7 cells expressing ectopic ICAM-1 in the presence of active MMP-13 induced inhibition of RAW 264.7 cell adhesion to COS-7 monolayers. MALDI-TOF MS analysis combined to Liquid chromatography coupled to Ion Trap MS on ICAM-1 incubated with MMP-13 allowed us to determine the cleavage sites of MMP-13 at positions E61 and G98 of ICAM-1. G98 is part of a PDGQS moiety, which shows homology with the consensus PDGLS substrate located at the MMP-13 cleaved site of type II collagen I-alpha.

Conclusions— Taking together, these results point toward MMP-13 as a mechanism for the NO-mediated protection of atherosclerosis.


Key Words: atherosclerosis • nitric oxide • NOS3/apoE-null mice • MMP-13 • ICAM-1




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
Nitric Oxide Induces the Progression of Abdominal Aortic Aneurysms through the Matrix Metalloproteinase Inducer EMMPRIN
Am. J. Pathol., October 1, 2009; 175(4): 1421 - 1430.